| 000 | 01762cam a2200361 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030226.0 | ||
| 008 | 100509s2010 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.08.08.M.Sc.2010.Am.P | ||
| 100 | 0 | _aAmr Mostafa Yassin | |
| 245 | 1 | 2 |
_aA pharmaceutical study on celecoxib / _cAmr Mostafa Yassin ; Supervised Samia Abdelkader Nour , Abdallah Mahmoud Molokhia , Omaima Naim Elgazayerly |
| 246 | 1 | 5 | _aدراسة صيدلية على عقار سيلوكوكسيب |
| 260 |
_aCairo : _bAmr Mostafa Yassin , _c2010 |
||
| 300 |
_a199P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics | ||
| 520 | _aNon - steroidal anti - inflammatory drugs are widely used for controlling inflammation however the patient may suffer from undesirable side effects such as gastric ulceration altering platelet function and renal toxicity due to inhibition of COX - 1 enzyme . These side effects are minimum in case of selective COX - 2 drugs . Multiple acute or chronic exposure to the harmful range of UV radiation (UVB) may lead on long terms to serious consequences including skin cancer in susceptible persons | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aA pharmaceutical study | |
| 653 | 4 | _aAnti - inflammatory | |
| 653 | 4 | _aCelecoxib | |
| 700 | 0 |
_aAbdallah Mahmoud Molokhia , _eSupervisor |
|
| 700 | 0 |
_aOmaima Naim Elgazayerly , _eSupervisor |
|
| 700 | 0 |
_aSamia Abdelkader Nour , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 902 | _a1 | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aMustafa _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c30236 _d30236 |
||